Synthetic biology gets a makeover with Evonetix’s DNA synthesis technology

Could benchtop DNA synthesizers finally become a reality? Matthew Hayes, Chief Technology Officer and Co-Founder at Evonetix, thinks so. “What we aspire to do is to provide an instrument that will automatically synthesize whole genes,” he says. “If we can do that it will revolutionize the way people currently do synthetic biology.”

Read the full article, published via SynBioBeta here.